163 related articles for article (PubMed ID: 10050880)
1. CD44 cleavage induced by a membrane-associated metalloprotease plays a critical role in tumor cell migration.
Okamoto I; Kawano Y; Tsuiki H; Sasaki J; Nakao M; Matsumoto M; Suga M; Ando M; Nakajima M; Saya H
Oncogene; 1999 Feb; 18(7):1435-46. PubMed ID: 10050880
[TBL] [Abstract][Full Text] [Related]
2. Soluble CD44 inhibits melanoma tumor growth by blocking cell surface CD44 binding to hyaluronic acid.
Ahrens T; Sleeman JP; Schempp CM; Howells N; Hofmann M; Ponta H; Herrlich P; Simon JC
Oncogene; 2001 Jun; 20(26):3399-408. PubMed ID: 11423990
[TBL] [Abstract][Full Text] [Related]
3. Chondroitin sulfate E fragments enhance CD44 cleavage and CD44-dependent motility in tumor cells.
Sugahara KN; Hirata T; Tanaka T; Ogino S; Takeda M; Terasawa H; Shimada I; Tamura J; ten Dam GB; van Kuppevelt TH; Miyasaka M
Cancer Res; 2008 Sep; 68(17):7191-9. PubMed ID: 18757435
[TBL] [Abstract][Full Text] [Related]
4. Probing the infiltrating character of brain tumors: inhibition of RhoA/ROK-mediated CD44 cell surface shedding from glioma cells by the green tea catechin EGCg.
Annabi B; Bouzeghrane M; Moumdjian R; Moghrabi A; Béliveau R
J Neurochem; 2005 Aug; 94(4):906-16. PubMed ID: 15992376
[TBL] [Abstract][Full Text] [Related]
5. Cleavage of the HER2 ectodomain is a pervanadate-activable process that is inhibited by the tissue inhibitor of metalloproteases-1 in breast cancer cells.
Codony-Servat J; Albanell J; Lopez-Talavera JC; Arribas J; Baselga J
Cancer Res; 1999 Mar; 59(6):1196-201. PubMed ID: 10096547
[TBL] [Abstract][Full Text] [Related]
6. Rho-kinase (ROK) promotes CD44v(3,8-10)-ankyrin interaction and tumor cell migration in metastatic breast cancer cells.
Bourguignon LY; Zhu H; Shao L; Zhu D; Chen YW
Cell Motil Cytoskeleton; 1999; 43(4):269-87. PubMed ID: 10423269
[TBL] [Abstract][Full Text] [Related]
7. CD44v(3,8-10) is involved in cytoskeleton-mediated tumor cell migration and matrix metalloproteinase (MMP-9) association in metastatic breast cancer cells.
Bourguignon LY; Gunja-Smith Z; Iida N; Zhu HB; Young LJ; Muller WJ; Cardiff RD
J Cell Physiol; 1998 Jul; 176(1):206-15. PubMed ID: 9618160
[TBL] [Abstract][Full Text] [Related]
8. Interaction between CD44 and the repeat domain of ankyrin promotes hyaluronic acid-mediated ovarian tumor cell migration.
Zhu D; Bourguignon LY
J Cell Physiol; 2000 May; 183(2):182-95. PubMed ID: 10737894
[TBL] [Abstract][Full Text] [Related]
9. Roles of MMP/TIMP in regulating matrix swelling and cell migration during chick corneal development.
Huh MI; Lee YM; Seo SK; Kang BS; Chang Y; Lee YS; Fini ME; Kang SS; Jung JC
J Cell Biochem; 2007 Aug; 101(5):1222-37. PubMed ID: 17295208
[TBL] [Abstract][Full Text] [Related]
10. CD44v10 interaction with Rho-kinase (ROK) activates inositol 1,4,5-triphosphate (IP3) receptor-mediated Ca2+ signaling during hyaluronan (HA)-induced endothelial cell migration.
Singleton PA; Bourguignon LY
Cell Motil Cytoskeleton; 2002 Dec; 53(4):293-316. PubMed ID: 12378540
[TBL] [Abstract][Full Text] [Related]
11. Role of CD44s and CD44v6 on human breast cancer cell adhesion, migration, and invasion.
Afify A; Purnell P; Nguyen L
Exp Mol Pathol; 2009 Apr; 86(2):95-100. PubMed ID: 19167378
[TBL] [Abstract][Full Text] [Related]
12. Hyaluronan-CD44 interaction hampers migration of osteoclast-like cells by down-regulating MMP-9.
Spessotto P; Rossi FM; Degan M; Di Francia R; Perris R; Colombatti A; Gattei V
J Cell Biol; 2002 Sep; 158(6):1133-44. PubMed ID: 12235127
[TBL] [Abstract][Full Text] [Related]
13. CD44 is involved in migration but not spreading of astrocytoma cells in vitro.
Radotra B; McCormick D
Anticancer Res; 1997; 17(2A):945-9. PubMed ID: 9137432
[TBL] [Abstract][Full Text] [Related]
14. Hyaluronate binding assay study of transfected CD44 V4-V7 isoforms into the human gastric carcinoma cell line SC-M1.
Harn HJ; Shen KL; Liu CA; Ho LI; Yang LS; Yueh KC
J Pathol; 1998 Mar; 184(3):291-6. PubMed ID: 9614382
[TBL] [Abstract][Full Text] [Related]
15. The role of the hyaluronan receptor CD44 in mesenchymal stem cell migration in the extracellular matrix.
Zhu H; Mitsuhashi N; Klein A; Barsky LW; Weinberg K; Barr ML; Demetriou A; Wu GD
Stem Cells; 2006 Apr; 24(4):928-35. PubMed ID: 16306150
[TBL] [Abstract][Full Text] [Related]
16. Hyaluronate and its receptors in bone marrow.
Schade UM; Nehmann N; Horny HP; Prehm P; Delpech B; Krüger WH; Zander AR; Schumacher U
Acta Histochem; 2006; 108(2):141-7. PubMed ID: 16713618
[TBL] [Abstract][Full Text] [Related]
17. Transforming growth factor-beta induces CD44 cleavage that promotes migration of MDA-MB-435s cells through the up-regulation of membrane type 1-matrix metalloproteinase.
Kuo YC; Su CH; Liu CY; Chen TH; Chen CP; Wang HS
Int J Cancer; 2009 Jun; 124(11):2568-76. PubMed ID: 19243022
[TBL] [Abstract][Full Text] [Related]
18. CD44 crosslinking-mediated matrix metalloproteinase-9 relocation in breast tumor cells leads to enhanced metastasis.
Peng ST; Su CH; Kuo CC; Shaw CF; Wang HS
Int J Oncol; 2007 Nov; 31(5):1119-26. PubMed ID: 17912438
[TBL] [Abstract][Full Text] [Related]
19. CD44 cross-linking induces integrin-mediated adhesion and transendothelial migration in breast cancer cell line by up-regulation of LFA-1 (alpha L beta2) and VLA-4 (alpha4beta1).
Wang HS; Hung Y; Su CH; Peng ST; Guo YJ; Lai MC; Liu CY; Hsu JW
Exp Cell Res; 2005 Mar; 304(1):116-26. PubMed ID: 15707579
[TBL] [Abstract][Full Text] [Related]
20. Novel peptide inhibitors of Leishmania gp63 based on the cleavage site of MARCKS (myristoylated alanine-rich C kinase substrate)-related protein.
Corradin S; Ransijn A; Corradin G; Bouvier J; Delgado MB; Fernandez-Carneado J; Mottram JC; Vergères G; Mauël J
Biochem J; 2002 Nov; 367(Pt 3):761-9. PubMed ID: 12137567
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
